Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by...
Illumina launches TruPath Genome, setting a new standard in genomic insight
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease Broad Clinical Labs is among first to adopt product, which was previously known as "constellation mapped read technology" SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced...
Canadian hospital now ranked #2 in the world
UHN achieves highest-ever position in Newsweek's World's Best Hospitals ranking TORONTO, Feb. 25, 2026 /PRNewswire/ -- University Health Network's Toronto General Hospital has ranked second in the world in Newsweek magazine's World's Best Hospitals 2026, marking the highest position ever achieved by a Canadian hospital. This also marks the eighth consecutive year that University Health Network has been ranked...
Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize
A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat cancer, while antibiotics may impair its effect by reducing intestinal microbiota diversity. PORTO, Portugal, Feb. 25, 2026 /PRNewswire/ -- An international consortium of 48 researchers from institutions in France, Sweden, and the...
World Gym Corporation Will Participate in Fireside Chat with IPO Edge on February 27, 2026
TAIPEI, Feb. 25, 2026 /PRNewswire/ -- World Gym Corporation (2762.TW) ("World Gym" or the "Company"), the owner of the iconic World Gym brand with over 280 locations worldwide, today announced that its President, John Caraccio, and Executive Committee Member, Mark Harms, will participate in a Fireside Chat with IPO Edge and The...
Polaroid Therapeutics (PTx) Receives CE Mark for POLTX_Fiber™: the first application of APT™ to launch a new standard in wound care
Introducing Antimicrobial Polymer Technology (APT™) in POLTX_Fiber™, a Class IIb advanced wound care dressing that does not contribute to antimicrobial resistance: offering improved wound management through the prevention of bacterial colonization within the dressing. ZURICH, Feb. 25, 2026 /PRNewswire/ -- Polaroid Therapeutics (PTx) today announces that POLTX_Fiber™ has received the CE Mark as...
Smartee Delivers Master Class on “Mandibular Repositioning” in Sydney at Invitation of EODO
SYDNEY, Feb. 14, 2026 /PRNewswire/ -- At the invitation of the Excellence in Orthodontics and Dentofacial Orthopedics (EODO), Smartee Denti-Technology held a specialized Master Class at the Dental Education Centre (DEC) in Sydney on February 7. This session attracted 80 dental professionals, with 60 attending in person and 20 joining online, to study advanced protocols for treating complex jaw discrepancies using...
SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platform Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares' leadership in biosimilars across Latin America Agreement marks the first product from this strategic partnership and Shilpa Biologicals' entry into the Latin American market ...
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
SHANGHAI and HONG KONG, Feb. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies, announced that it has entered into a clinical collaboration agreement with...
Direct Genome-Scale Mapping of Endonuclease Activity of the Human LINE-1 ORF2p Endonuclease
Nabsys and the Research Lab of Dr. Martin Taylor, Brown University, Present Data Using the OhmX™ Platform at AGBT 2026 PROVIDENCE, R.I., Feb. 25, 2026 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping (EGM) technology, today announced new findings presented at the Advances in Genome Biology and Technology...
